Reviva Pharmaceuticals Holdings, Inc. (RVPHW)의 가격은 얼마입니까?

Reviva Pharmaceuticals Holdings, Inc. (RVPHW)의 가격은 $0.003입니다.

Reviva Pharmaceuticals Holdings, Inc. (RVPHW)의 시가 총액은 무엇입니까?

Reviva Pharmaceuticals Holdings, Inc. (RVPHW)의 시가 총액은 $343.91K입니다.

Reviva Pharmaceuticals Holdings, Inc. (RVPHW) 가격 이력

Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing innovative therapies for diseases with substantial unmet medical needs. Their pipeline targets disorders within the central nervous system, respiratory, cardiovascular, metabolic, and inflammatory disease categories. The company's leading drug candidate, brilaroxazine (RP5063), is currently in Phase III clinical trials for the treatment of schizophrenia. This compound has also completed Phase I trials for a diverse set of conditions, including bipolar disorder, major depressive disorder, attention-deficit/hyperactivity disorder, the behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis. Furthermore, Reviva is advancing RP1208, which is in pre-clinical development for depression and obesity. Founded in 2018, the company is headquartered in Cupertino, California.

연도	성과
2026 (TTM)	305.88%
2025	-96.70%
2024	-75.67%
2023	0.82%
2022	134.68%
2021	-39.09%
2020	167.36%
2019	-15.00%
2018	0.00%

연도

성과

2026 (TTM)

305.88%

2025

-96.70%

2024

-75.67%

2023

0.82%

2022

134.68%

2021

-39.09%

2020

167.36%

2019

-15.00%

2018

0.00%

회사	주가	변동률 1년%	국가
Vertex Pharmaceuticals Incorporated VRTX.US	$517.18	32.51%	US
Argenx SE ARGX.US	$857.76	31.47%	NL
Lonza Group AG LONN.SW	$739.76	8.31%	CH
Samsung Biologics Co.,Ltd. 207940.KS	$1.07K	-6.40%	KR
UCB S.A. UCB.BR	$258.70	14.29%	BE

회사

주가

변동률 1년%

국가